KevinBryanLo Profile Banner
Kevin Bryan Lo Profile
Kevin Bryan Lo

@KevinBryanLo

Followers
203
Following
208
Media
1
Statuses
10

Cardiology Fellow @BrighamFellows | IM, Chief Resident &Hospitalist @JeffHealthEH | MD, BSN @UST1611Official 🇵🇭

Joined July 2011
Don't wanna be here? Send us removal request.
@KevinBryanLo
Kevin Bryan Lo
2 years
Sharing our project in cardio-kidney-metabolic disease Thank you very much to my mentors @RangaswJ @ChiadiNdumele Sheryl Chow for all the learning, guidance and priceless experience! a pleasure working with @BigeOzkanMD, one of the most organized and efficient people I’ve met
@AHAScience
AHA Science
2 years
Cardiovascular-Kidney-Metabolic Syndrome: a health disorder due to connections among obesity, diabetes, chronic kidney disease & CVD. 📖 @CircAHA ✍️ Chiadi E. Ndumele, MD, PhD, MHS & @RangaswJ More on defining, screening, and treating this syndrome: https://t.co/Tm2DlaXMaE
3
4
24
@mvaduganathan
Muthu Vaduganathan
3 years
Happening Now 📢 @ERAkidney #JournalClub! Incoming @BrighamFellows @KevinBryanLo sharing his @NDTsocial paper Nonsteroidal #MRA & Cardiorenal Outcomes MR takes center stage over next several yrs in #HF #CKD #rHTN @willkidney @P_Rossing @RangaswJ 📎 https://t.co/ch4OvU4Zv9
0
9
42
@RangaswJ
Janani Rangaswami
3 years
Delighted to contribute to this special issue of @NDTsocial with @mvaduganathan @KevinBryanLo on# non-steroidal MRAs and #cardiorenal outcomes in #CKD @KidneyInCVD @AgarwalRajivMD @denisfouque1
@AgarwalRajivMD
Rajiv Agarwal MD, MS
3 years
Borrowing from heart failure concepts and extending them to ckd, here are the foundations and pillars concept for managing cardiorenal risk n t2d. Sequencing okay but should be prompt. Time on treatment translates 2 cardiorenal protection https://t.co/i7KNPrvYZh @denisfouque1
0
2
6
@mvaduganathan
Muthu Vaduganathan
3 years
A Welcome ‘Failure’ of Gliflozins: #BloodPressure Reduction in #HeartFailure in @escardio #EHJ @Kieranfdocherty & @PSJhund highlight the relative hemodynamical neutrality of #SGLT2i in HF, facilitating their ease of use. Average BP ↓ of just <2-3mmHg! https://t.co/a4o1Q4RxsM
1
37
103
@emory_heart
Emory Cardiology Fell🫀ws
3 years
#FlashbackFriday to #Match2022 when had the honor of welcoming these wonderful folks to @emory_heart! Our colleagues and patients are lucky to have you and we can’t wait to have you onboard as fellows. @BRWilliamsMD @ozlembilen2 @KunalBhattMD
3
7
33
@KevinBryanLo
Kevin Bryan Lo
3 years
I would like to thank the Lord for so much blessings, my family, my wife Janice, my parents and sister, Cricky and friends, my dear mentors Dr Rangaswami @RangaswJ , my mentors at Einstein @EinsteinHealth, my mentors from Hawaii and the Philippines, this is a dream come true!
14
2
57
@RangaswJ
Janani Rangaswami
3 years
Super proud of my #cardiorenal superstar mentee @KevinBryanLo for matching @BrighamWomen’s cardiology fellowship. The #cardiorenal space is in great hands with such talent @mvaduganathan @EinsteinHealth @AHAScience @RajgopalRadhika
@BrighamFellows
Brigham & Women's CV Fellows
3 years
Welcome future colleagues! We are so excited to see what you accomplish. #Match2023 #CardioTwitter
5
4
37
@RangaswJ
Janani Rangaswami
3 years
Important new ⁦@AHAScience@KidneyInCVD #statement ⁩ Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association ⁦@KristaLentine
Tweet card summary image
ahajournals.org
Coronary heart disease is an important source of mortality and morbidity among kidney transplantation and liver transplantation candidates and recipients and is driven by traditional and nontraditi...
1
16
23
@RangaswJ
Janani Rangaswami
3 years
15
141
430